SCHEMBL17630102

SCHEMBL17630102

N#Cc1ccc(-c2ccc(-n3ccnc3)cc2)c(CCC(N)=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 2/20 0.47
PDE1A P54750 2/20 0.47
PDE1B Q01064 2/20 0.47
PDE3B Q13370 2/20 0.47
PDE1C Q14123 2/20 0.47
PDE3A Q14432 2/20 0.47
ADH5 P11766 9/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP19A1 P11511 1/20 0.43
TBXAS1 P24557 2/20 0.41
CYP2C19 P33261 1/20 0.39
CYP3A4 P08684 2/20 0.38
BAZ2B Q9UIF8 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
MEN1 O00255 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629984 0.85 PDE2A (0.50) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17629946 0.83 ADH5 (0.47) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17643466 0.82 PDE2A (0.49) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630064 0.81 PDE2A (0.46) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630062 0.80 ADH5 (0.47) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17642945 0.80 PDE3B (0.50) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630080 0.80 PDE2A (0.46) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630079 0.78 CYP3A4 (0.52) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630146 0.78 PDE2A (0.47) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17629950 0.78 PDE2A (0.48) PDE2APDE1APDE1BPDE3BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed